The site will be unavailable in 5 minutes for scheduled maintenance.

$53.75 0.02 (+0.04%)
2/10/2012 4:00 PM

Gilead Sciences, Inc. (NASDAQ:GILD)

CAPS Rating: 5 out of 5

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Featured Broker Partners


Advertisement